Shai Mulinari
71 – 80 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Många allvarliga brott mot regler när läkemedel marknadsförs
(
- Contribution to journal › Letter
-
Mark
Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden
(
- Contribution to journal › Article
-
Mark
Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant
(
- Contribution to journal › Article
-
Mark
Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
(
- Contribution to journal › Article
-
Mark
Measures of discriminatory accuracy and categorizations in public health: a response to Allan Krasnik's editorial.
(
- Contribution to journal › Letter
-
Mark
Etik och marknadsföring: Skäl till självkritik?
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Replik, etik och marknadsföring: Inte för sent för reformer
(
- Contribution to journal › Letter
-
Mark
Money, Money, Money? Politico-Moral Discourses of Stem Cell Research in a Grant Allocation Process
(
- Contribution to journal › Article
- 2014
-
Mark
The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning
(
- Contribution to journal › Article
- 2013
-
Mark
Misleading advertising for antidepressants in sweden: a failure of pharmaceutical industry self-regulation.
(
- Contribution to journal › Article